Liver Injury and the Activation of the Hepatic Myofibroblasts

Current Pathobiology Reports

Volumn 1, Issue 3, 2013, Pages 215-223

  Jiang, Joy X ^a   Török, Natalie J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Apoptosis; Gut microbiota; miRNA; Reactive oxidative species; Sterile inflammation

Indexed keywords

EID: 84899924689     PISSN: None     EISSN: 2167485X     Source Type: Journal    
DOI: 10.1007/s40139-013-0019-6     Document Type: Review

References (100)

1. D’Amico G, Garcia-Tsao G, Pagliaro L (2006) Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol 44:217–231
2. Lee UE, Friedman SL (2011) Mechanisms of hepatic fibrogenesis. Best Pract Res Clin Gastroenterol 25:195–206
3. Wells RG (2013) Tissue mechanics and fibrosis. Biochim Biophys Acta 1832:884–890
4. Mormone E, George J, Nieto N (2011) Molecular pathogenesis of hepatic fibrosis and current therapeutic approaches. Chem Biol Interact 193:225–231
5. Wynn TA (2008) Cellular and molecular mechanisms of fibrosis. J Pathol 214:199–210
6. Cong M, Iwaisako K, Jiang C, Kisseleva T (2012) Cell signals influencing hepatic fibrosis. Int J Hepatol 2012:158547
7. Friedman SL (2000) Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem 275:2247–2250
8. Buscemi L, Ramonet D, Klingberg F, Formey A, Smith-Clerc J, Meister JJ, Hinz B (2011) The single-molecule mechanics of the latent TGF-beta1 complex. Curr Biol 21:2046–2054
9. Benyon RC, Arthur MJ (2001) Extracellular matrix degradation and the role of hepatic stellate cells. Semin Liver Dis 21:373–384
10. Han YP (2006) Matrix metalloproteinases, the pros and cons, in liver fibrosis. J Gastroenterol Hepatol 21(Suppl 3):S88–S91
11. Kinnman N, Francoz C, Barbu V, Wendum D, Rey C, Hultcrantz R, Poupon R et al (2003) The myofibroblastic conversion of peribiliary fibrogenic cells distinct from hepatic stellate cells is stimulated by platelet-derived growth factor during liver fibrogenesis. Lab Invest 83:163–173
12. Bosselut N, Housset C, Marcelo P, Rey C, Burmester T, Vinh J, Vaubourdolle M et al (2010) Distinct proteomic features of two fibrogenic liver cell populations: hepatic stellate cells and portal myofibroblasts. Proteomics 10:1017–1028
13. Wells RG, Kruglov E, Dranoff JA (2004) Autocrine release of TGF-beta by portal fibroblasts regulates cell growth. FEBS Lett 559:107–110
14. Dranoff JA, Wells RG (2010) Portal fibroblasts: underappreciated mediators of biliary fibrosis. Hepatology 51:1438–1444
15. Malhi H, Gores GJ (2008) Cellular and molecular mechanisms of liver injury. Gastroenterology 134:1641–1654
16. Malhi H, Gores GJ (2008) Molecular mechanisms of lipotoxicity in nonalcoholic fatty liver disease. Semin Liver Dis 28:360–369
17. Ibrahim SH, Kohli R, Gores GJ (2011) Mechanisms of lipotoxicity in NAFLD and clinical implications. J Pediatr Gastroenterol Nutr 53:131–140
18. Czaja MJ (2011) Two types of autophagy are better than one during hepatocyte oxidative stress. Autophagy 7:96–97
19. Amir M, Zhao E, Fontana L, Rosenberg H, Tanaka K, Gao G, Czaja MJ (2013) Inhibition of hepatocyte autophagy increases tumor necrosis factor-dependent liver injury by promoting caspase-8 activation. Cell Death Differ. doi:10.1038/cdd.2013.21
20. Ibrahim SH, Gores GJ (2012) Who pulls the trigger: JNK activation in liver lipotoxicity? J Hepatol 56:17–19
21. Nishitoh H (2012) CHOP is a multifunctional transcription factor in the ER stress response. J Biochem 151:217–219
22. Ji C, Kaplowitz N, Lau MY, Kao E, Petrovic LM, Lee AS (2011) Liver-specific loss of glucose-regulated protein 78 perturbs the unfolded protein response and exacerbates a spectrum of liver diseases in mice. Hepatology 54:229–239
23. Xu J, Lai KK, Verlinsky A, Lugea A, French SW, Cooper MP, Ji C et al (2011) Synergistic steatohepatitis by moderate obesity and alcohol in mice despite increased adiponectin and p-AMPK. J Hepatol 55:673–682
24. Saeed M, Suzuki R, Watanabe N, Masaki T, Tomonaga M, Muhammad A, Kato T et al (2011) Role of the endoplasmic reticulum-associated degradation (ERAD) pathway in degradation of hepatitis C virus envelope proteins and production of virus particles. J Biol Chem 286:37264–37273
25. Merquiol E, Uzi D, Mueller T, Goldenberg D, Nahmias Y, Xavier RJ, Tirosh B et al (2011) HCV causes chronic endoplasmic reticulum stress leading to adaptation and interference with the unfolded protein response. PLoS One 6:e24660
26. Reinehr R, Haussinger D (2012) CD95 death receptor and epidermal growth factor receptor (EGFR) in liver cell apoptosis and regeneration. Arch Biochem Biophys 518:2–7
27. • Guicciardi ME, Gores GJ (2010) Apoptosis as a mechanism for liver disease progression. Semin Liver Dis 30:402–410. The authors review the main pathways of apoptosis and its contribution to fibrosis
28. Elliott MR, Chekeni FB, Trampont PC, Lazarowski ER, Kadl A, Walk SF, Park D et al (2009) Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance. Nature 461:282–286
29. Dranoff JA, Ogawa M, Kruglov EA, Gaca MD, Sevigny J, Robson SC, Wells RG (2004) Expression of P2Y nucleotide receptors and ectonucleotidases in quiescent and activated rat hepatic stellate cells. Am J Physiol Gastrointest Liver Physiol 287:G417–G424
30. Jiang JX, Venugopal S, Serizawa N, Chen X, Scott F, Li Y, Adamson R et al (2010) Reduced nicotinamide adenine dinucleotide phosphate oxidase 2 plays a key role in stellate cell activation and liver fibrogenesis in vivo. Gastroenterology 139:1375–1384
31. Canbay A, Feldstein AE, Higuchi H, Werneburg N, Grambihler A, Bronk SF, Gores GJ (2003) Kupffer cell engulfment of apoptotic bodies stimulates death ligand and cytokine expression. Hepatology 38:1188–1198
32. Watanabe A, Hashmi A, Gomes DA, Town T, Badou A, Flavell RA, Mehal WZ (2007) Apoptotic hepatocyte DNA inhibits hepatic stellate cell chemotaxis via toll-like receptor 9. Hepatology 46:1509–1518
33. Miura K, Kodama Y, Inokuchi S, Schnabl B, Aoyama T, Ohnishi H, Olefsky JM et al (2010) Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1beta in mice. Gastroenterology 139(323–334):e327
34. • Henao-Mejia J, Elinav E, Strowig T, Flavell RA (2012) Inflammasomes: far beyond inflammation. Nat Immunol 13:321–324. This is a recent update on the role of inflammasomes and their role in disease progression
35. Kono H, Rock KL (2008) How dying cells alert the immune system to danger. Nat Rev Immunol 8:279–289
36. Rodrigue-Gervais IG, Saleh M (2013) Caspases and immunity in a deadly grip. Trends Immunol 34:41–49
37. Rubartelli A, Gattorno M, Netea MG, Dinarello CA (2011) Interplay between redox status and inflammasome activation. Trends Immunol 32:559–566
38. •• Kubes P, Mehal WZ (2012) Sterile inflammation in the liver. Gastroenterology 143:1158–1172. The authors provide a detailed and excellent summary on DAMP-induced sterile inflammation and inflammasome signaling in liver diseases
39. McDonald B, Pittman K, Menezes GB, Hirota SA, Slaba I, Waterhouse CC, Beck PL et al (2010) Intravascular danger signals guide neutrophils to sites of sterile inflammation. Science 330:362–366
40. Wang X, Sun R, Wei H, Tian Z (2013) High-mobility group box 1 (HMGB1)-Toll-like receptor (TLR)4-interleukin (IL)-23-IL-17A axis in drug-induced damage-associated lethal hepatitis: Interaction of gammadelta T cells with macrophages. Hepatology 57:373–384
41. Wang X, Bu HF, Zhong W, Asai A, Zhou Z, Tan XD (2013) MFG-E8 and HMGB1 are involved in the mechanism underlying alcohol-induced impairment of macrophage engulfing apoptotic cells. Mol Med. doi:10.2119/molmed.2012.00260
42. Sato S, St-Pierre C, Bhaumik P, Nieminen J (2009) Galectins in innate immunity: dual functions of host soluble beta-galactoside-binding lectins as damage-associated molecular patterns (DAMPs) and as receptors for pathogen-associated molecular patterns (PAMPs). Immunol Rev 230:172–187
43. Henderson NC, Mackinnon AC, Farnworth SL, Poirier F, Russo FP, Iredale JP, Haslett C et al (2006) Galectin-3 regulates myofibroblast activation and hepatic fibrosis. Proc Natl Acad Sci USA 103:5060–5065
44. Jiang JX, Chen X, Hsu DK, Baghy K, Serizawa N, Scott F, Takada Y et al (2012) Galectin-3 modulates phagocytosis-induced stellate cell activation and liver fibrosis in vivo. Am J Physiol Gastrointest Liver Physiol 302:G439–G446
45. Nomoto K, Nishida T, Nakanishi Y, Fujimoto M, Takasaki I, Tabuchi Y, Tsuneyama K (2012) Deficiency in galectin-3 promotes hepatic injury in CDAA diet-induced nonalcoholic fatty liver disease. ScientificWorldJournal 2012:959824
46. Iacobini C, Menini S, Ricci C, Blasetti Fantauzzi A, Scipioni A, Salvi L, Cordone S et al (2011) Galectin-3 ablation protects mice from diet-induced NASH: a major scavenging role for galectin-3 in liver. J Hepatol 54:975–983
47. Dragomir AC, Sun R, Choi H, Laskin JD, Laskin DL (2012) Role of galectin-3 in classical and alternative macrophage activation in the liver following acetaminophen intoxication. J Immunol 189:5934–5941
48. Volarevic V, Milovanovic M, Ljujic B, Pejnovic N, Arsenijevic N, Nilsson U, Leffler H et al (2012) Galectin-3 deficiency prevents concanavalin A-induced hepatitis in mice. Hepatology 55:1954–1964
49. MacKinnon AC, Farnworth SL, Hodkinson PS, Henderson NC, Atkinson KM, Leffler H, Nilsson UJ et al (2008) Regulation of alternative macrophage activation by galectin-3. J Immunol 180:2650–2658
50. Henderson NC, Sethi T (2009) The regulation of inflammation by galectin-3. Immunol Rev 230:160–171
51. Dixon LJ, Flask CA, Papouchado BG, Feldstein AE, Nagy LE (2013) Caspase-1 as a central regulator of high fat diet-induced non-alcoholic steatohepatitis. PLoS One 8:e56100
52. Petrasek J, Bala S, Csak T, Lippai D, Kodys K, Menashy V, Barrieau M et al (2012) IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice. J Clin Invest 122:3476–3489
53. Weng HL, Liu Y, Chen JL, Huang T, Xu LJ, Godoy P, Hu JH et al (2009) The etiology of liver damage imparts cytokines transforming growth factor beta1 or interleukin-13 as driving forces in fibrogenesis. Hepatology 50:230–243
54. Holt AP, Salmon M, Buckley CD, Adams DH (2008) Immune interactions in hepatic fibrosis. Clin Liver Dis 12:861–882, x
55. Gordon S, Martinez FO (2010) Alternative activation of macrophages: mechanism and functions. Immunity 32:593–604
56. Meng F, Wang K, Aoyama T, Grivennikov SI, Paik Y, Scholten D, Cong M, et al. (2012) Interleukin-17 signaling in inflammatory, Kupffer cells, and hepatic stellate cells exacerbates liver fibrosis in mice. Gastroenterology 143:765–776 e761-763
57. Gao B, Radaeva S (2012) Natural killer and natural killer T cells in liver fibrosis. Biochim Biophys Acta 1832:1061–1069
58. Radaeva S, Wang L, Radaev S, Jeong WI, Park O, Gao B (2007) Retinoic acid signaling sensitizes hepatic stellate cells to NK cell killing via upregulation of NK cell activating ligand RAE1. Am J Physiol Gastrointest Liver Physiol 293:G809–G816
59. Saile B, Eisenbach C, Dudas J, El-Armouche H, Ramadori G (2004) Interferon-gamma acts proapoptotic on hepatic stellate cells (HSC) and abrogates the antiapoptotic effect of interferon-alpha by an HSP70-dependant pathway. Eur J Cell Biol 83:469–476
60. Jeong WI, Park O, Gao B (2008) Abrogation of the antifibrotic effects of natural killer cells/interferon-gamma contributes to alcohol acceleration of liver fibrosis. Gastroenterology 134:248–258
61. Jeong WI, Park O, Suh YG, Byun JS, Park SY, Choi E, Kim JK et al (2011) Suppression of innate immunity (natural killer cell/interferon-gamma) in the advanced stages of liver fibrosis in mice. Hepatology 53:1342–1351
62. • Tian Z, Chen Y, Gao B (2013) Natural killer cells in liver disease. Hepatology 57:1654–1662. The authors summarize the most advanced findings on the role of NK cells in liver diseases
63. Park O, Jeong WI, Wang L, Wang H, Lian ZX, Gershwin ME, Gao B (2009) Diverse roles of invariant natural killer T cells in liver injury and fibrosis induced by carbon tetrachloride. Hepatology 49:1683–1694
64. Syn WK, Oo YH, Pereira TA, Karaca GF, Jung Y, Omenetti A, Witek RP et al (2010) Accumulation of natural killer T cells in progressive nonalcoholic fatty liver disease. Hepatology 51:1998–2007
65. Wehr A, Baeck C, Heymann F, Niemietz PM, Hammerich L, Martin C, Zimmermann HW et al (2013) Chemokine receptor CXCR6-dependent hepatic NK T cell accumulation promotes inflammation and liver fibrosis. J Immunol 190:5226–5236
66. Jaeschke H (2011) Reactive oxygen and mechanisms of inflammatory liver injury: present concepts. J Gastroenterol Hepatol 26(Suppl 1):173–179
67. Lieber CS (2004) Alcoholic fatty liver: its pathogenesis and mechanism of progression to inflammation and fibrosis. Alcohol 34:9–19
68. De Minicis S, Brenner DA (2007) NOX in liver fibrosis. Arch Biochem Biophys 462:266–272
69. 3 engagement and PI3K/pAkt/NFκB signaling. Hepatology 55:594–608
70. Novo E, Parola M (2012) The role of redox mechanisms in hepatic chronic wound healing and fibrogenesis. Fibrogenesis Tissue Repair 5(Suppl 1):S4
71. Hernandez-Gea V, Hilscher M, Rozenfeld R, Lim MP, Nieto N, Werner S, Devi LA et al (2013) Endoplasmic reticulum stress induces fibrogenic activity in hepatic stellate cells through autophagy. J Hepatol S0168–8278:001384–001394
72. Paik YH, Iwaisako K, Seki E, Inokuchi S, Schnabl B, Osterreicher CH, Kisseleva T et al (2011) The nicotinamide adenine dinucleotide phosphate oxidase (NOX) homologues NOX1 and NOX2/gp91(phox) mediate hepatic fibrosis in mice. Hepatology 53:1730–1741
73. Cui W, Matsuno K, Iwata K, Ibi M, Matsumoto M, Zhang J, Zhu K et al (2011) NOX1/nicotinamide adenine dinucleotide phosphate, reduced form (NADPH) oxidase promotes proliferation of stellate cells and aggravates liver fibrosis induced by bile duct ligation. Hepatology 54:949–958
74. Sancho P, Mainez J, Crosas-Molist E, Roncero C, Fernandez-Rodriguez CM, Pinedo F, Huber H et al (2012) NADPH oxidase NOX4 mediates stellate cell activation and hepatocyte cell death during liver fibrosis development. PLoS One 7:e45285
75. Kis K, Liu X, Hagood JS (2011) Myofibroblast differentiation and survival in fibrotic disease. Expert Rev Mol Med 13:e27
76. Jiang JX, Mikami K, Venugopal S, Li Y, Torok NJ (2009) Apoptotic body engulfment by hepatic stellate cells promotes their survival by the JAK/STAT and Akt/NF-kappaB-dependent pathways. J Hepatol 51:139–148
77. Aoyama T, Paik YH, Watanabe S, Laleu B, Gaggini F, Fioraso-Cartier L, Molango S et al (2012) Nicotinamide adenine dinucleotide phosphate oxidase in experimental liver fibrosis: GKT137831 as a novel potential therapeutic agent. Hepatology 56:2316–2327
78. Jiang JX, Chen X, Serizawa N, Szyndralewiez C, Page P, Schroder K, Brandes RP et al (2012) Liver fibrosis and hepatocyte apoptosis are attenuated by GKT137831, a novel NOX4/NOX1 inhibitor in vivo. Free Radic Biol Med 53:289–296
79. Omenetti A, Choi S, Michelotti G, Diehl AM (2011) Hedgehog signaling in the liver. J Hepatol 54:366–373
80. Robbins DJ, Fei DL, Riobo NA (2012) The Hedgehog signal transduction network. Sci Signal 5:re6
81. • Choi SS, Omenetti A, Syn WK, Diehl AM (2011) The role of Hedgehog signaling in fibrogenic liver repair. Int J Biochem Cell Biol 43:238–244. This is a state-of-the art summary of the current knowledge of Hedgehog signaling in liver diseases
82. Chen Y, Choi SS, Michelotti GA, Chan IS, Swiderska-Syn M, Karaca GF, Xie G, et al. (2012) Hedgehog controls hepatic stellate cell fate by regulating metabolism. Gastroenterology 143:1319–1329.e11
83. Hernandez-Gea V, Ghiassi-Nejad Z, Rozenfeld R, Gordon R, Fiel MI, Yue Z, Czaja MJ et al (2012) Autophagy releases lipid that promotes fibrogenesis by activated hepatic stellate cells in mice and in human tissues. Gastroenterology 142:938–946
84. Kluwe J, Wongsiriroj N, Troeger JS, Gwak GY, Dapito DH, Pradere JP, Jiang H et al (2011) Absence of hepatic stellate cell retinoid lipid droplets does not enhance hepatic fibrosis but decreases hepatic carcinogenesis. Gut 60:1260–1268
85. Yan AW, Schnabl B (2012) Bacterial translocation and changes in the intestinal microbiome associated with alcoholic liver disease. World J Hepatol 4:110–118
86. Fouts DE, Torralba M, Nelson KE, Brenner DA, Schnabl B (2012) Bacterial translocation and changes in the intestinal microbiome in mouse models of liver disease. J Hepatol 56:1283–1292
87. Machado MV, Cortez-Pinto H (2012) Gut microbiota and nonalcoholic fatty liver disease. Ann Hepatol 11:440–449
88. • Seki E, Schnabl B (2012) Role of innate immunity and the microbiota in liver fibrosis: crosstalk between the liver and gut. J Physiol 590:447–458. The authors summarize the most important mechanisms by which the gut–liver axis is regulated
89. Paik YH, Schwabe RF, Bataller R, Russo MP, Jobin C, Brenner DA (2003) Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells. Hepatology 37:1043–1055
90. Dapito DH, Mencin A, Gwak GY, Pradere JP, Jang MK, Mederacke I, Caviglia JM et al (2012) Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4. Cancer Cell 21:504–516
91. Henao-Mejia J, Elinav E, Jin C, Hao L, Mehal WZ, Strowig T, Thaiss CA et al (2012) Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature 482:179–185
92. Hartmann P, Haimerl M, Mazagova M, Brenner DA, Schnabl B (2012) Toll-like receptor 2-mediated intestinal injury and enteric tumor necrosis factor receptor I contribute to liver fibrosis in mice. Gastroenterology 143(1330–1340):e1331
93. He Y, Huang C, Zhang SP, Sun X, Long XR, Li J (2012) The potential of microRNAs in liver fibrosis. Cell Signal 24:2268–2272
94. Lakner AM, Steuerwald NM, Walling TL, Ghosh S, Li T, McKillop IH, Russo MW et al (2012) Inhibitory effects of microRNA 19b in hepatic stellate cell-mediated fibrogenesis. Hepatology 56:300–310
95. Ogawa T, Iizuka M, Sekiya Y, Yoshizato K, Ikeda K, Kawada N (2010) Suppression of type I collagen production by microRNA-29b in cultured human stellate cells. Biochem Biophys Res Commun 391:316–321
96. Vickers KC, Remaley AT (2012) Lipid-based carriers of microRNAs and intercellular communication. Curr Opin Lipidol 23:91–97
97. Bala S, Petrasek J, Mundkur S, Catalano D, Levin I, Ward J, Alao H et al (2012) Circulating microRNAs in exosomes indicate hepatocyte injury and inflammation in alcoholic, drug-induced, and inflammatory liver diseases. Hepatology 56:1946–1957
98. She H, Xiong S, Hazra S, Tsukamoto H (2005) Adipogenic transcriptional regulation of hepatic stellate cells. J Biol Chem 280:4959–4967
99. Yang MD, Chiang YM, Higashiyama R, Asahina K, Mann DA, Mann J, Wang CC et al (2012) Rosmarinic acid and baicalin epigenetically derepress peroxisomal proliferator-activated receptor gamma in hepatic stellate cells for their antifibrotic effect. Hepatology 55:1271–1281
100. Zeybel M, Hardy T, Wong YK, Mathers JC, Fox CR, Gackowska A, Oakley F et al (2012) Multigenerational epigenetic adaptation of the hepatic wound-healing response. Nat Med 18:1369–1377